Market Access Navigating new risks: How China’s Anti-Espionage Law could i... The pharmaceutical industry is facing another challenge as China seems to strengthen its Anti-Espionage Law, which introduces uncertainties that could disrupt the global supply of essential
Digital How to conduct a cybersecurity audit on your pharma supply c... Drug manufacturers, wholesale distributors and pharmacies stepped up during the COVID-19 pandemic to preserve supply chain integrity.
Digital Innovating pharma: How technology can ensure a steady medica... The pharmaceutical industry faces an urgent challenge: frequent drug shortages that threaten patient care and public health.
R&D Supply chain resilience in pharma: Delivering consistency am... In an interconnected economy, industries operating on an international scale are increasingly vulnerable to supply chain disruption.
R&D Reducing drug shortages: The power of AI in pharma supply ch... Drug shortages have long been a challenge in the pharmaceutical industry, causing significant disruptions to patient care and public health.
News UK MHRA green lights AbbVie’s ELAHERE for ovarian cancer AbbVie has secured UK marketing authorisation for ELAHERE (mirvetuximab soravtansine), the first antibo
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
